Date published: 2026-2-23

1-800-457-3801

SCBT Portrait Logo
Seach Input

cathepsin W Activators

Cathepsin W activators are a diverse group of chemical compounds that indirectly enhance the functional activity of Cathepsin W by influencing various proteolytic regulatory mechanisms within the cell. These activators work by creating a compensatory demand for Cathepsin W's proteolytic action when other proteases are inhibited. For instance, Cystatin, E-64, and Leupeptin are inhibitors of other cysteine and serine proteases, which when inhibited, may lead to an increased functional need for Cathepsin W's activity to maintain proteolytic balance within the cell. Similarly, Pepstatin A, by specifically inhibiting aspartic proteases, might cause the cellular system to rely more heavily on Cathepsin W for proteolysis. The targeted suppression of proteasomal degradation pathways by MG-132 and Lactacystin potentially leads to a greater dependence on lysosomal proteases like Cathepsin W, indirectly enhancing its activity. These compounds collectively demonstrate the ability of cellular systems to adaptively upregulate Cathepsin W activity in response to the inhibition of other proteolytic players. Further indirect activation of Cathepsin W is achieved through the inhibition of closely related proteases by compounds like CA-074, which selectively inhibits Cathepsin B, and Aloxistatin, which inhibits a broad range of cysteine proteases except Cathepsin W, suggesting a compensatory increase in Cathepsin W's activity due to decreased proteolytic redundancy. Chymostatin's role in inhibiting chymotrypsin-like activities may similarly lead to a greater reliance on Cathepsin W for such proteolytic functions within the lysosome. The specific inhibition of other pathways by compounds such as Z-FA-FMK, Calpeptin, as well as the selective inhibition by Cathepsin Inhibitor I, all contribute to a biochemical environment that necessitates the enhanced activity of Cathepsin W to fulfill the proteolytic demand, thereby demonstrating the interconnectedness of proteolytic regulation and the pivotal role of Cathepsin W within these processes.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Calpeptin

117591-20-5sc-202516
sc-202516A
10 mg
50 mg
$121.00
$456.00
28
(1)

Calpeptin is a calpain inhibitor; inhibition of calpain may shift the cellular reliance on lysosomal proteases like cathepsin W for protein degradation.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG-132 is a proteasome inhibitor; suppression of proteasomal degradation pathways can lead to increased reliance and activation of lysosomal proteases such as cathepsin W.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Lactacystin is another proteasome inhibitor; by inhibiting proteasomal degradation, cathepsin W activity can be indirectly enhanced as an alternative degradation pathway.

E-64

66701-25-5sc-201276
sc-201276A
sc-201276B
5 mg
25 mg
250 mg
$281.00
$947.00
$1574.00
14
(0)

Aloxistatin, also known as E-64-d, is an epoxysuccinyl peptide and inhibitor of cysteine proteases; it can lead to the compensatory activation of cathepsin W.

CA-074

134448-10-5sc-202513
1 mg
$321.00
(0)

CA-074 is a selective cathepsin B inhibitor; its specificity can indirectly enhance cathepsin W activity due to reduced proteolytic redundancy.

Chymostatin

9076-44-2sc-202541
sc-202541A
sc-202541B
sc-202541C
sc-202541D
5 mg
10 mg
25 mg
50 mg
100 mg
$156.00
$260.00
$640.00
$1186.00
$2270.00
3
(1)

Chymostatin is a chymotrypsin inhibitor which may lead to the enhanced reliance on cathepsin W for chymotrypsin-like proteolytic activities in the lysosome.